Abstract CT192: Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2
Year: 2019
Type: conference-abstract
Source: Cancer Research
Authors: Alexander Drilon, Fabrice Barlesi, Filippo De Braud, Byoung Chul Cho, Myung-Ju Ahn, Salvatore Siena, Matthew G. Krebs, Chia-Chi Lin, Tom John, Daniel SW Tan, Takashi Seto, Rafal Dziadziuszko, Hendrick-Tobias Arkenau, Christian Rolfo, Jürgen Wolf, Chenglin Ye, Todd Riehl, Susan Eng, Robert C. Doebele
Institutions: Memorial Sloan Kettering Cancer Center, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Yonsei Cancer Hospital, Samsung Medical Center, Sungkyunkwan University, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, University of Manchester, The Christie NHS Foundation Trust, National Taiwan University, Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, National Cancer Centre Singapore, National Hospital Organization Kyushu Cancer Center, Gdańsk Medical University, Sarah Cannon Research Institute, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University Hospital Cologne, Genentech
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4235179667